Đang chuẩn bị liên kết để tải về tài liệu:
Novel polymorphisms in caspase-8 are associated with breast cancer risk in the California teachers study

Phương Nhung 47 8 pdf

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ Tải xuống

The ability of tamoxifen and raloxifene to decrease breast cancer risk varies among different breast cancer subtypes. It is important to determine one’s subtype-specific breast cancer risk when considering chemoprevention. A number of single nucleotide polymorphisms (SNPs), including one in caspase-8 (CASP8), have been previously associated with risk of developing breast cancer. |

TÀI LIỆU LIÊN QUAN

Discovering novel SNPs that are correlated with patient outcome in a Singaporean cancer patient cohort treated with gemcitabine-based chemotherapy

Five novel PRNP gene polymorphisms and their potential effect on Scrapie susceptibility in three native Ethiopian sheep breeds

THE FACTORS AFFECTING THE USE OF ELDERLY CARE AND THE NEED FOR RESOURCES BY 2030 IN FINLAND

Early and locally advanced breast cancer: diagnosis and treatment

GLOBAL HEALTH RISKS - Mortality and burden of disease attributable to selected major risks

AIR POLLUTION STUDIES No. 15: EMISSION REPORTING GUIDELINES

A Guide for Tourism Business Entrepreneurs

Báo cáo y học: " Phylogenetic classification of Escherichia coli O157:H7 strains of human and bovine origin using a novel set of nucleotide polymorphisms"

ESMO Hb Cancer Prevention

STOCK RETURNS AND THE WEEKEND EFFECT

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.